Customer reviews for Psilera, Inc.

No reviews yet. Share the first one.

Psilera, Inc.

Psychedelic medicine developer

Founded in 2019, Psilera, Inc. develops investigational neuroplastogens, including compounds designed to reduce hallucinogenic effects. Its pipeline is preclinical, and the company anticipates first-in-human testing of its lead candidate, PSIL-006, in 2027. Psilera is active and based in Tampa, Florida; no ownership changes were specified. Its candidates are investigational and are not available to buy.

Website
psilera.com

Psilera, Inc. catalog

All products · Psychedelic medicine pipeline

Shop the Psilera, Inc. catalog

5 items across 1 shelf

Psychedelic medicine pipeline5 items